{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-015231","form_type":"8-K","ticker":"COO","cik":"0000711404","company_name":"COOPER COMPANIES, INC.","filed_at":"2026-03-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.513764+00:00","generated_at":"2026-05-15T20:19:05.456951+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CooperCompanies Q1 revenue $1.024B, non-GAAP EPS $1.10; raises FY2026 guidance","bullets":["Q1 revenue $1.024B (+6% reported, +3% organic); GAAP EPS $0.66 (+27%), non-GAAP EPS $1.10 (+20%).","CVI revenue $695.1M (+8% reported, +3% organic); Toric/multifocal +10% reported, sphere +5%.","CSI revenue $329.0M (+3% reported, +2% organic); Fertility +6% reported, Office/surgical +2%.","FY2026 guidance raised: revenue $4.306-$4.346B, non-GAAP EPS $4.58-$4.66, free cash flow $600-$625M.","Repurchased $92.5M in stock (~1.1M shares at avg $82.04); $873.9M remaining authorization."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-015231","json":"https://secwatch.observer/filing/0001628280-26-015231.json","markdown":"https://secwatch.observer/filing/0001628280-26-015231.md","text":"https://secwatch.observer/filing/0001628280-26-015231.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/711404/000162828026015231/0001628280-26-015231-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/711404/000162828026015231/coo-20260305.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T20:19:05.456951+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}